Sinovac Life Sciences Co., Ltd.
27
4
4
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 27 trials
100.0%
+13.5% vs industry average
33%
9 trials in Phase 3/4
0%
0 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (27)
Clinical Trial of PCV24 in Adults Aged ≥18 Years
Role: lead
The Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)
Role: lead
Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine
Role: lead
Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate Vaccine
Role: lead
Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine
Role: lead
Clinical Trial of PCV24 in Infants Aged 2-23 Months
Role: lead
Clinical Trial of PCV24 in Children Aged 2-17 Years
Role: lead
Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years
Role: lead
PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)
Role: lead
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants
Role: lead
Clinical Trial of PCV24 in Adults
Role: lead
Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population
Role: lead
Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals
Role: collaborator
Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile
Role: collaborator
SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients
Role: lead
Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 Vaccine
Role: lead
Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents
Role: lead
Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents
Role: lead
SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19
Role: lead
SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People
Role: lead